Hemagglutinin glycosylation modulates the pathogenicity and antigenicity of the H5N1 avian influenza virus

Veterinary Microbiology

Volumn 175, Issue 2-4, 2015, Pages 244-256

  Zhang, Xiaojian ^a,b,c   Chen, Sujuan ^a,b,c   Jiang, Yi ^a,b,c   Huang, Kai ^a,b,c   Huang, Jun ^a,b,c   Yang, Da ^a,b,c   Zhu, Jingjing ^a,b,c   Zhu, Yinbiao ^a,b,c   Shi, Shaohua ^a,b,c   Peng, Daxin ^a,b,c   Liu, Xiufan ^a,b,c  

^a YANGZHOU UNIVERSITY   (China)

^b Jiangsu Co innovation Center for Prevention Control of Important Animal Infectious Diseases and Zoonoses   (China)

^c Jiangsu Research Centre of Engineering and Technology for Prevention   (China)

Author keywords

Antigenicity; Avian influenza virus; Glycosylation; Hemagglutinin; Pathogenicity

Indexed keywords

AVIAN INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY;

A549 CELL LINE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHICKEN; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS PROTECTION; CROSS REACTION; EMBRYO; GROWTH RATE; HEMAGGLUTINATION TEST; HUMAN; HUMAN CELL; IMMUNOGENICITY; INFLUENZA VIRUS A H5N1; MDCK CELL LINE; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN GLYCOSYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; VIROGENESIS; VIRUS ATTACHMENT; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TITRATION; VIRUS VIRULENCE; ANIMAL; AVIAN INFLUENZA; BIRD DISEASE; GENE EXPRESSION REGULATION; GENETICS; GLYCOSYLATION; IMMUNOLOGY; INFLUENZA A VIRUS (H5N1); METABOLISM; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

AVIAN INFLUENZA VIRUS; GALLUS GALLUS; MUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; CHICKENS; CROSS REACTIONS; GENE EXPRESSION REGULATION, VIRAL; GLYCOSYLATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; MICE; MUTAGENESIS, SITE-DIRECTED; ORTHOMYXOVIRIDAE INFECTIONS; POULTRY DISEASES; VIRULENCE;

EID: 84922742404     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.12.011     Document Type: Article

References (55)

1. Baigent S.J., McCauley J.W. Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture. Virus Res. 2001, 79:177-185.
2. Bogs J., Kalthoff D., Veits J., Pavlova S., Schwemmle M., Manz B., Mettenleiter T.C., Stech J. Reversion of PB2-627E to -627K during replication of an H5N1 Clade 2.2 virus in mammalian hosts depends on the origin of the nucleoprotein. J. Virol. 2011, 85:10691-10698.
3. Bright R.A., Ross T.M., Subbarao K., Robinson H.L., Katz J.M. Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology 2003, 308:270-278.
4. Chen H., Deng G., Li Z., Tian G., Li Y., Jiao P., Zhang L., Liu Z., Webster R.G., Yu K. The evolution of H5N1 influenza viruses in ducks in southern China. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10452-10457.
5. Chen W., Sun S., Li Z. Two glycosylation sites in H5N1 influenza virus hemagglutinin that affect binding preference by computer-based analysis. PLoS ONE 2012, 7:e38794.
6. Chen W., Zhong Y., Qin Y., Sun S., Li Z. The evolutionary pattern of glycosylation sites in influenza virus (H5N1) hemagglutinin and neuraminidase. PLoS ONE 2012, 7:e49224.
7. Cheung C., Poon L., Lau A., Luk W., Lau Y., Shortridge K., Gordon S., Guan Y., Peiris J. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 2002, 360:1831-1837.
8. Das S.R., Puigbo P., Hensley S.E., Hurt D.E., Bennink J.R., Yewdell J.W. Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog. 2010, 6:e1001211.
9. Deshpande K.L., Fried V.A., Ando M., Webster R.G. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:36-40.
10. Gao Y., Zhang Y., Shinya K., Deng G., Jiang Y., Li Z., Guan Y., Tian G., Li Y., Shi J. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog. 2009, 5:e1000709.
11. Gu M., Zhao G., Zhao K., Zhong L., Huang J., Wan H., Wang X., Liu W., Liu H., Peng D., Liu X. Novel variants of clade 2.3.4 highly pathogenic avian influenza A(H5N1) viruses, China. Emerg. Infect. Dis. 2013, 19:2021-2024.
12. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6108-6113.
13. Hoyer L.L., Roggentin P., Schauer R., Vimr E.R. Purification and properties of cloned Salmonella typhimurium LT2 sialidase with virus-typical kinetic preference for sialyl alpha 2,3 linkages. J. Biochem. 1991, 110:462-467.
14. Hu J., Hu Z., Song Q., Gu M., Liu X., Wang X., Hu S., Chen C., Liu H., Liu W., Chen S., Peng D. The PA-gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice. J. Virol. 2013, 87:2660-2672.
15. Igarashi M., Ito K., Kida H., Takada A. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin. Virology 2008, 376:323-329.
16. Kim J.I., Park M.S. N-linked glycosylation in the hemagglutinin of influenza A viruses. Yonsei Med. J. 2012, 53:886-893.
17. Kobayashi Y., Suzuki Y. Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin. J. Virol. 2012, 86:3446-3451.
18. Liao H.Y., Hsu C.H., Wang S.C., Liang C.H., Yen H.Y., Su C.Y., Chen C.H., Jan J.T., Ren C.T., Chen C.H. Differential receptor binding affinities of influenza hemagglutinins on glycan arrays. J. Am. Chem. Soc. 2010, 132:14849-14856.
19. Lowen A.C., Mubareka S., Steel J., Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 2007, 3:1470-1476.
20. Matrosovich M., Zhou N., Kawaoka Y., Webster R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 1999, 73:1146-1155.
21. Matsuoka Y., Swayne D.E., Thomas C., Rameix-Welti M.A., Naffakh N., Warnes C., Altholtz M., Donis R., Subbarao K. Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice. J. Virol. 2009, 83:4704-4708.
22. Negovetich N.J., Webster R.G. Thermostability of subpopulations of H2N3 influenza virus isolates from mallard ducks. J. Virol. 2010, 84:9369-9376.
23. Ohuchi M., Ohuchi R., Feldmann A., Klenk H.D. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J. Virol. 1997, 71:8377-8384.
24. Ohuchi R., Ohuchi M., Garten W., Klenk H.D. Oligosaccharides in the stem region maintain the influenza virus hemagglutinin in the metastable form required for fusion activity. J. Virol. 1997, 71:3719-3725.
25. Peiris J., Yu W., Leung C., Cheung C., Ng W., Nicholls J.A., Ng T., Chan K., Lai S., Lim W. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004, 363:617-619.
26. Proenca-Modena J.L., Macedo I.S., Arruda E. H5N1 avian influenza virus: an overview. Braz. J. Infect. Dis. 2007, 11:125-133.
27. Reading P.C., Pickett D.L., Tate M.D., Whitney P.G., Job E.R., Brooks A.G. Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir. Res. 2009, 10:117.
28. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 1938, 27:493-497.
29. Reed M.L., Bridges O.A., Seiler P., Kim J.K., Yen H.L., Salomon R., Govorkova E.A., Webster R.G., Russell C.J. The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. J. Virol. 2010, 84:1527-1535.
30. Rigoni M., Toffan A., Viale E., Mancin M., Cilloni F., Bertoli E., Salomoni A., Marciano S., Milani A., Zecchin B., Capua I., Cattoli G. The mouse model is suitable for the study of viral factors governing transmission and pathogenesis of highly pathogenic avian influenza (HPAI) viruses in mammals. Vet. Res. 2010, 41:66.
31. Rossman J.S., Lamb R.A. Influenza virus assembly and budding. Virology 2011, 411:229-236.
32. Shinya K., Ebina M., Yamada S., Ono M., Kasai N., Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006, 440:435-436.
33. Skehel J., Stevens D., Daniels R., Douglas A., Knossow M., Wilson I., Wiley D. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:1779-1783.
34. Song J., Feng H., Xu J., Zhao D., Shi J., Li Y., Deng G., Jiang Y., Li X., Zhu P., Guan Y., Bu Z., Kawaoka Y., Chen H. The PA protein directly contributes to the virulence of H5N1 avian influenza viruses in domestic ducks. J. Virol. 2011, 85:2180-2188.
35. Steel J., Lowen A.C., Mubareka S., Palese P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 2009, 5:e1000252.
36. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006, 312:404-410.
37. Sun S., Wang Q., Zhao F., Chen W., Li Z. Glycosylation site alteration in the evolution of influenza A (H1N1) viruses. PLoS ONE 2011, 6:e22844.
38. Sun X., Jayaraman A., Maniprasad P., Raman R., Houser K.V., Pappas C., Zeng H., Sasisekharan R., Katz J.M., Tumpey T.M. N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses. J. Virol. 2013, 87:8756-8766.
39. Suptawiwat O., Kongchanagul A., Chan-It W., Thitithanyanont A., Wiriyarat W., Chaichuen K., Songserm T., Suzuki Y., Puthavathana P., Auewarakul P. A simple screening assay for receptor switching of avian influenza viruses. J. Clin. Virol. 2008, 42:186-189.
40. Tang Y., Wu P., Peng D., Wang X., Wan H., Zhang P., Long J., Zhang W., Li Y., Wang W., Zhang X., Liu X. Characterization of duck H5N1 influenza viruses with differing pathogenicity in mallard (Anas platyrhynchos) ducks. Avian Pathol. 2009, 38:457-467.
41. Tang Y., Wu P., Sun Q., Peng D., Zhang W., Li Y., Wang W., Long J., Zhang P., Liu X. Role of amino acid residues at positions 322 and 329 of hemagglutinin in virulence of H5N1 avian influenza virus. Chin. J. Virol. 2008, 24:340-344.
42. Tate M.D., Job E.R., Brooks A.G., Reading P.C. Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice. Virology 2011, 413:84-92.
43. Tsuchiya E., Sugawara K., Hongo S., Matsuzaki Y., Muraki Y., Nakamura K. Role of overlapping glycosylation sequons in antigenic properties, intracellular transport and biological activities of influenza A/H2N2 virus haemagglutinin. J. Gen. Virol. 2002, 83:3067-3074.
44. Tumpey T.M., Maines T.R., Van Hoeven N., Glaser L., Solorzano A., Pappas C., Cox N.J., Swayne D.E., Palese P., Katz J.M., Garcia-Sastre A. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 2007, 315:655-659.
45. Vigerust D.J., Ulett K.B., Boyd K.L., Madsen J., Hawgood S., McCullers J.A. N-linked glycosylation attenuates H3N2 influenza viruses. J. Virol. 2007, 81:8593-8600.
46. Wagner R., Wolff T., Herwig A., Pleschka S., Klenk H.D. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J. Virol. 2000, 74:6316-6323.
47. Wang C.C., Chen J.R., Tseng Y.C., Hsu C.H., Hung Y.F., Chen S.W., Chen C.M., Khoo K.H., Cheng T.J., Cheng Y.S.E. Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18137-18142.
48. Wang W., Lu B., Zhou H., Suguitan A.L., Cheng X., Subbarao K., Kemble G., Jin H. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets. J. Virol. 2010, 84:6570-6577.
49. Wanzeck K., Boyd K.L., McCullers J.A. Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am. J. Respir. Crit. Care Med. 2011, 183:767.
50. Wei C.J., Boyington J.C., Dai K., Houser K.V., Pearce M.B., Kong W.P., Yang Z.Y., Tumpey T.M., Nabel G.J. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2010, 2(24):ra21.
51. Wiley D., Wilson I., Skehel J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981, 289:373-378.
52. Yen H.L., Aldridge J.R., Boon A.C., Ilyushina N.A., Salomon R., Hulse-Post D.J., Marjuki H., Franks J., Boltz D.A., Bush D. Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:286-291.
53. Zhang M., Gaschen B., Blay W., Foley B., Haigwood N., Kuiken C., Korber B. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004, 14:1229-1246.
54. Zhang W., Xue T., Wu X., Zhang P., Zhao G., Peng D., Hu S., Wang X., Liu X., Liu W. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk. Vaccine 2011, 29:8032-8041.
55. Zhang Y., Zhu J., Li Y., Bradley K.C., Cao J., Chen H., Jin M., Zhou H. Glycosylation on hemagglutinin affects the virulence and pathogenicity of pandemic H1N1/2009 influenza A virus in mice. PLoS ONE 2013, 8:e61397.